Prelude Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $456K | Buy |
|
|||||
|
2024
Q4 | $171K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $25K | Sell |
|
|||||
|
2020
Q2 | $187K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $313K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $23K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $259K | Buy |
|
|||||
|
2017
Q4 | $6K | Sell |
|
|||||
|
2017
Q3 | $398K | Sell |
|
|||||
|
2017
Q2 | $893K | Buy |
|
|||||
|
2017
Q1 | $412K | Buy |
|
|||||
|
2016
Q4 | $189K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $157K | Sell |
|
|||||
|
2016
Q1 | $181K | Sell |
|
|||||
|
2015
Q4 | $831K | Buy |
|
|||||
|
2015
Q3 | $314K | Sell |
|
|||||
|
2015
Q2 | $534K | Buy |
|
|||||
|
2015
Q1 | $294K | Sell |
|
|||||
|
2014
Q4 | $429K | Buy |
|
|||||
|
2014
Q3 | $326K | Sell |
|
|||||
|
2014
Q2 | $354K | Sell |
|
|||||
|
2014
Q1 | $612K | Buy |
|
|||||
|
2013
Q4 | $263K | Hold |
|
|||||
|
2013
Q3 | $242K | Sell |
|
|||||
|
2013
Q2 | $673K | Buy |
|